Overview
Good Documentation Practice (GDP) is a set of principles and procedures for the creation, handling, maintenance, and retention of documentation in the pharmaceutical industry. Documentation is the backbone of GMP compliance, providing the evidence that products were manufactured and tested according to established procedures. Poor documentation is one of the most common findings during regulatory inspections, making GDP training essential for all personnel who create, review, or manage pharmaceutical records .
https://www.gxptrainings.com/course-category/gmp-training
What Is Good Documentation Practice (GDP)?
Good Documentation Practice is a systematic approach to managing documentation throughout its lifecycle. It ensures that records are accurate, complete, and reliable. The principles of GDP are closely aligned with the ALCOA+ principles for data integrity.
ALCOA+ Principles – The foundation of Good Documentation Practice is ALCOA+, which stands for Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available .
Attributable – Data should be traceable to the person who recorded it. This means that records should include the identity of the person who created or modified the data.
Legible – Data should be readable and permanent. Handwritten entries should be clear and in ink, and electronic records should be maintained in a readable format.
Contemporaneous – Data should be recorded at the time of the activity. This ensures that records accurately reflect what happened and when.
Original – Data should be the first recording of the information. If data is transcribed, the original record should be retained.
Accurate – Data should be correct and without errors. Corrections should be made in a way that does not obscure the original entry.
Why Good Documentation Practice Is Important
Good Documentation Practice is critical for several reasons. Documentation provides the evidence that products were manufactured in compliance with GMP requirements. Without proper documentation, there is no proof of compliance.
Evidence of Compliance – Documentation provides the evidence that products were manufactured and tested according to GMP requirements. This is essential for regulatory inspections.
Traceability – Documentation allows for the tracing of products from raw materials to finished products. This is essential for investigations, recalls, and corrective actions.
Risk Management – Complete and accurate documentation demonstrates that the organization has addressed risks. Incomplete or inaccurate records are a significant compliance risk.
Inspection Readiness – Proper documentation is essential for passing regulatory inspections. Incomplete or inaccurate records are a common cause of regulatory citations .
Who Needs Good Documentation Practice Training?
Good Documentation Practice training is required for all personnel who create, review, or manage documentation in the pharmaceutical industry. This includes a wide range of roles across the organization.
Quality Assurance Personnel – QA professionals must understand GDP principles to ensure that documentation meets regulatory requirements.
Quality Control Personnel – QC staff must understand GDP principles to ensure that laboratory records are accurate and complete .
Production and Manufacturing Staff – Operators, supervisors, and managers must understand GDP principles to ensure that batch records and other manufacturing documents are complete and accurate.
Regulatory Affairs Professionals – Regulatory professionals must understand GDP principles to ensure that submissions are based on accurate and complete documentation.
Warehouse and Logistics Staff – Warehouse personnel must understand GDP principles to ensure that inventory records are accurate and traceable.
Detailed Course Breakdown
Course 1: EU GMP Auditor Certification
This training program defines the complete knowledge and performance requirements for personnel involved in pharmaceutical manufacturing to become certified auditors for Good Manufacturing Practice in the European Union regulatory environment.
Scope: The program integrates EU GMP requirements from EudraLex Volume 4 (Part I, Part II, and relevant Annexes) with auditing practices based on ISO 19011:2026 for internal, second-party (vendor, CRO, and supplier), and global regulatory compliance auditing.
Description of Modules: The curriculum covers:
- Regulatory Frameworks including EU GMP Guide, Part I, Part II, Annexes 1, 2, 3, and 7
- Auditing Practices based on ISO 19011:2026 including seven auditing principles
- Pharmaceutical Quality System and Quality Risk Management
- Personnel qualifications, training, hygiene, and gowning requirements
- Premises design, cleanroom classifications, and barrier technologies
- Equipment qualification (DQ, IQ, OQ, PQ) and maintenance
- Documentation systems and Good Documentation Practices
- Production operations and cross-contamination prevention
- Process validation, cleaning validation, and revalidation
- Quality Control laboratory operations and stability testing
- Sterile product manufacturing including aseptic processing
- Biological product manufacturing including viral clearance
- Supplier qualification and supply chain auditing
Target Audience:
- Quality Assurance Personnel
- Quality Control Personnel
- Production and Manufacturing Staff
- Qualified Persons (QPs)
- Engineering and Maintenance Personnel
- Warehouse and Logistics Staff
- Regulatory Affairs Professionals
- Supplier Qualification Professionals
- Contract Manufacturing Organization Personnel
- Microbiology and Sterility Assurance Personnel
- Validation Personnel
- Audit Program Managers
- Regulatory Compliance Officers
Pricing: Competitive pricing with group discounts available.
FAQ:
- What are the prerequisites for this course? Participants should have a basic understanding of pharmaceutical manufacturing and GMP principles.
- What is ISO 19011:2026? ISO 19011:2026 provides guidelines for auditing management systems.
- What are the seven principles of auditing? The seven principles are integrity, fair presentation, due professional care, confidentiality, independence, evidence-based approach, and risk-based approach.
- What are the key areas of focus for EU inspectors? Inspectors focus heavily on quality risk management and the QP’s declaration of product quality.
- Can I conduct regulatory inspections with this certification? No, the program is designed for global auditing across internal, second-party, and regulatory readiness contexts.
Enroll Now: https://www.gxptrainings.com/courses/eu-gmp-auditor-certification-program/
Course 2: cGMP Auditor Certification (FDA-Focused)
This training program defines the complete knowledge and performance requirements for personnel involved in pharmaceutical manufacturing to become certified auditors for Current Good Manufacturing Practice (cGMP) in the United States regulatory environment.
Scope: The program integrates FDA cGMP requirements from 21 CFR Part 210 (General Provisions) and 21 CFR Part 211 (Finished Pharmaceuticals) with auditing practices based on ISO 19011:2026 for internal, second-party (vendor, CRO, and supplier), and global regulatory compliance auditing.
Description of Modules: The curriculum covers:
- Regulatory Frameworks including 21 CFR Part 210 and 211
- Auditing Practices based on ISO 19011:2026 including seven auditing principles
- Quality Control Unit independence, approval and rejection authority
- Personnel Qualifications and responsibilities
- Buildings and Facilities design and construction
- Equipment design, cleaning, and calibration
- Components and Containers/Closures receipt and testing
- Production and Process Controls written procedures
- Packaging and Labeling materials examination
- Holding and Distribution warehousing and recall systems
- Laboratory Controls specifications and stability testing
- Records and Reports production and distribution records
Target Audience:
- Quality Assurance Personnel
- Quality Control Personnel
- Production and Manufacturing Staff
- Engineering and Maintenance Personnel
- Warehouse and Logistics Staff
- Regulatory Affairs Professionals
- Supplier Qualification Professionals
- Contract Manufacturing Organization Personnel
- Microbiology and Sterility Assurance Personnel
- Validation Personnel
- Audit Program Managers
- Regulatory Compliance Officers
Pricing: Competitive pricing with group discounts available.
FAQ:
- What is the difference between cGMP and GMP? cGMP refers to “Current” Good Manufacturing Practices, emphasizing the use of up-to-date systems and technologies.
- What are the legal consequences of FDA cGMP non-compliance? Drug products can be considered adulterated even if they pass testing but were made under improper conditions.
- What is the role of the Quality Control Unit in FDA cGMP? The Quality Control Unit has independence and authority to approve or reject all components and drug products.
- What are the historical foundations of FDA cGMP? The Elixir Sulfanilamide Disaster of 1937 and the Thalidomide Tragedy of the 1960s led to the establishment of cGMP requirements.
- What is a 483 observation? It is a form issued by the FDA to notify a company of violations observed during an inspection.
Enroll Now: https://www.gxptrainings.com/courses/cgmp-auditor-certification-program/
Course 3: GMP Auditor Certification (Health Canada Focused)
This training program defines the complete knowledge and performance requirements for personnel involved in pharmaceutical manufacturing to become certified auditors for Good Manufacturing Practices (GMP) in the Canadian regulatory environment.
Scope: The program integrates Health Canada GMP requirements from Part C, Division 2 of the Food and Drug Regulations, GUI-0001 (Good Manufacturing Practices Guide for Drug Products), GUI-0036 (Annex 13 – Drugs Used in Clinical Trials), and GUI-0104 (Good Manufacturing Practices for Active Pharmaceutical Ingredients) with auditing practices based on ISO 19011:2026 for internal, second-party (vendor, CRO, and supplier), and global regulatory compliance auditing.
Description of Modules: The curriculum covers:
- Regulatory Frameworks including Food and Drugs Act and Food and Drug Regulations
- Auditing Practices based on ISO 19011:2026
- Pharmaceutical Quality System and Quality Risk Management
- Personnel qualifications, training, hygiene, and clothing
- Premises design, construction, maintenance, and contamination prevention
- Equipment design, cleaning, calibration, and qualification
- Documentation systems and record-keeping requirements
- Sanitation programs including cleaning validation
- Raw material testing specifications and vendor certification
- Manufacturing control procedures and process validation
- Quality Control department independence and responsibilities
- Packaging material testing and label control
- Finished product testing and certificates of analysis
- Records and data integrity including ALCOA+ principles
- Stability programs including protocols and ongoing monitoring
Target Audience:
- Quality Assurance Personnel
- Quality Control Personnel
- Production and Manufacturing Staff
- Regulatory Affairs Professionals
- Supplier Qualification Professionals
- Contract Manufacturing Organization Personnel
- Microbiology and Sterility Assurance Personnel
- Validation Specialists
- Audit Program Managers
- Regulatory Compliance Officers
- Importers and Distributors of drugs
- Consultants to the pharmaceutical industry
Pricing: Competitive pricing with group discounts available.
FAQ:
- What is the difference between Health Canada GMP and FDA cGMP? Health Canada GMP is based on Part C, Division 2 of the Food and Drug Regulations and is harmonized with WHO, PIC/S, ICH, and VICH standards.
- What is the purpose of GUI-0036 (Annex 13)? GUI-0036 provides guidance for the fabrication and packaging/labelling of drugs intended for use in human clinical trials.
- What is the difference between GUI-0001 and GUI-0104? GUI-0001 is the Good Manufacturing Practices Guide for Drug Products, while GUI-0104 provides Good Manufacturing Practices for Active Pharmaceutical Ingredients.
- What is ALCOA+ and why is it important? ALCOA+ is a set of principles for ensuring data integrity in pharmaceutical records.
- What is the role of the Quality Control department in Health Canada GMP? The Quality Control department must have independence and defined responsibilities for sampling, testing, and approving or rejecting materials and products.
Enroll Now: https://www.gxptrainings.com/courses/gmp-auditor-certification-program/
Course 4: EU GMP Refresher
This refresher course focuses on critical updates, high-risk areas, common inspection findings, and advanced application of GMP principles in day-to-day pharmaceutical operations.
Scope: This program is designed to keep experienced professionals up to date with the latest changes in EU regulations. It focuses on recent updates and interpretations of the EU GMP guidelines, filtering out the noise and focusing on what has changed.
Description of Modules: Modules cover:
- Latest regulatory updates and guidance documents
- Inspection trends and enforcement actions
- Practical case studies from recent inspections
- Changes to the EU GMP guide and new Q&A documents
- EMA guidance on data integrity and risk management
- High-risk areas and common inspection findings
- Advanced application of GMP principles in daily operations
Target Audience:
- Experienced QA/QC managers
- Qualified Persons (QPs)
- Auditors who need to maintain their knowledge
- Quality Assurance Personnel
- Regulatory Affairs Professionals
- Production and Manufacturing Staff
Pricing: $149.00 with group discounts available.
FAQ:
- Is this course mandatory for QPs? While not mandatory, it is highly recommended to stay abreast of regulatory changes that affect the QP’s responsibilities.
- How often should I take a refresher course? It is recommended to take a refresher at least annually to stay current.
- How often does the EU update its GMP guidelines? The EU regularly publishes new guidance documents and revisions to existing annexes.
- What are the key areas of focus for EU inspectors? Inspectors focus heavily on quality risk management and the QP’s declaration of product quality.
- What is the difference between EU GMP and FDA cGMP? The core principles are similar, but EU GMP places a heavy emphasis on the Qualified Person role and specific Annexes.
Enroll Now: https://www.gxptrainings.com/courses/eu-gmp-refresher/
Course 5: FDA cGMP Refresher
This refresher course focuses on critical updates, high-risk areas, common inspection findings, and advanced application of cGMP principles in day-to-day pharmaceutical operations.
Scope: This program is designed to keep USFDA regulated professionals current with regulatory expectations. It covers recent enforcement trends, new guidance documents, and common 483 observations.
Description of Modules: Modules include:
- Data integrity and its importance
- Quality metrics and reporting
- Inspection readiness strategies
- Quality management maturity model
- Corrective actions and preventive measures
- Recent enforcement trends and common 483 observations
- Advanced application of cGMP principles in daily operations
Target Audience:
- QA personnel
- Regulatory compliance officers
- Manufacturing managers preparing for FDA audits
- Quality Control Personnel
- Production and Manufacturing Staff
- Regulatory Affairs Professionals
Pricing: $149.00 with group discounts available.
FAQ:
- What is data integrity and why is it important? Data integrity ensures that all data is complete, consistent, and accurate throughout the data lifecycle, which is a key focus of the FDA.
- What is a 483 observation? It is a form issued by the FDA to notify a company of violations observed during an inspection.
- What is the FDA’s stance on artificial intelligence in manufacturing? The FDA is actively working on guidance for the use of AI in drug manufacturing.
- Does the FDA accept online training? Yes, the FDA encourages training but requires that it be effective and verifiable.
- What are the legal consequences of FDA cGMP non-compliance? Drug products can be considered adulterated, leading to seizure, injunction, and prosecution.
Enroll Now: https://www.gxptrainings.com/courses/fda-cgmp-refresher/
Course 6: CQV Professional Certification (CQV-PC)
This training program provides comprehensive, practical knowledge of Commissioning, Qualification and Validation (CQV) principles and practices applicable to the life sciences industry.
Scope: The program covers the complete CQV lifecycle from project planning and requirements definition through commissioning, qualification, validation, documentation, risk management, deviations, change control, and lifecycle management.
Description of Modules: The curriculum covers:
- Introduction to CQV principles and practices
- Regulatory Expectations for CQV activities
- CQV Lifecycle and Planning frameworks
- URS, Design Review, and DQ requirements
- Risk-Based CQV and QRM methodologies
- Commissioning activities and documentation
- IQ, OQ, and PQ execution and documentation
- Facilities and Utilities qualification
- Equipment Qualification approaches
- Documentation and Change Control management
- Computerized Systems CQV requirements
- Life Sciences Applications across industry sectors
Target Audience:
- CQV professionals and validation specialists
- Commissioning engineers and qualification engineers
- Validation managers and validation leads
- Quality assurance professionals and QA managers
- Engineering professionals and facility engineers
- Manufacturing professionals and production managers
- Project managers and project engineers
- GMP consultants and compliance professionals
- Computerized system validation professionals
- Regulatory and compliance professionals
Pricing: $499.00 with group discounts available.
FAQ:
- How does CQV relate to GMP auditing? CQV ensures that facilities, utilities, and equipment are properly qualified and validated, which is a critical area of focus for GMP auditors.
- What is the difference between qualification and validation? Qualification demonstrates that equipment or utilities are fit for use, while validation demonstrates that a process consistently produces results meeting predetermined specifications.
- What is the CQV lifecycle? The CQV lifecycle includes project planning, requirements definition, commissioning, qualification, validation, documentation, risk management, deviations, change control, and lifecycle management.
- What is the difference between IQ, OQ, and PQ? IQ verifies correct installation, OQ verifies system function, and PQ verifies system performance under expected load.
- What is a Validation Master Plan? A Validation Master Plan is a high-level document that lays out scope, roles, timelines, and deliverables for a validation project.
Enroll Now: https://www.gxptrainings.com/courses/cqv-professional-certification-cqv-pc/
Course 7: Semiconductor Manufacturing
This comprehensive training program provides a systematic and detailed exploration of semiconductor manufacturing, covering the entire integrated circuit production process from wafer fabrication to final testing.
Scope: The program covers the entire semiconductor manufacturing process, including wafer fabrication, photolithography, etching, deposition, and packaging.
Description of Modules: The curriculum covers:
- Introduction to Semiconductor Manufacturing and the integrated circuit production process
- Wafer Fabrication – crystal growth, slicing, and polishing
- Photolithography – mask making, exposure, and development
- Etching – wet and dry etching processes
- Deposition – chemical vapor deposition and physical vapor deposition
- Packaging and Testing – assembly, packaging, and electrical testing
- Quality Control and yield management
- Cleanroom Requirements for semiconductor manufacturing
Target Audience:
- Manufacturing engineers and technicians
- Quality assurance professionals
- Process engineers and scientists
- Facilities and equipment engineers
- Supply chain and logistics professionals
- Regulatory affairs specialists
- Project managers and project engineers
- GMP consultants and compliance professionals
Pricing: $899.00 with group discounts available.
FAQ:
- What is semiconductor manufacturing? Semiconductor manufacturing is the process of creating integrated circuits used in electronic devices.
- What are the key steps in semiconductor manufacturing? Key steps include wafer fabrication, photolithography, etching, deposition, and packaging and testing.
- What is photolithography? Photolithography is the process of transferring circuit patterns onto a semiconductor wafer.
- What is the role of cleanrooms in semiconductor manufacturing? Cleanrooms are essential to prevent contamination that would damage integrated circuits.
- What is yield management? Yield management is the process of maximizing the number of functional chips produced per wafer.
Enroll Now: https://www.gxptrainings.com/courses/semiconductor-manufacturing/
Course 8: Validating AI in GxP
This comprehensive training program provides a deep and practical understanding of how to validate, govern, and maintain AI systems in GxP-regulated environments.
Scope: The program integrates the latest regulatory frameworks, including EU GMP Annex 11, the new Draft Annex 22, FDA’s Computer Software Assurance Guidance, 21 CFR Part 11, and the ISPE GAMP Guide: Artificial Intelligence.
Description of Modules: The curriculum covers 25 comprehensive sections across six parts:
- Part 1: Getting Your Bearings – AI concepts, regulatory spine, and why AI validation breaks traditional CSV
- Part 2: Classify and Govern – classification and risk tiering, AI governance operating model, and AI validation master plan
- Part 3: Build the Evidence – data governance for AI, performance acceptance criteria, test data and the three independences, and IQ/OQ/PQ redefined for AI
- Part 4: Keep It Valid Over Time – ongoing monitoring and drift response, explainability and confidence, change control and retraining, and AI risk management
- Part 5: Prove It and Scale It – inspection readiness, generative AI in non-critical GxP use, LLMs in regulated environments, and building the AI programme
- Part 6: Advanced Topics – AI and data integrity (ALCOA+), cybersecurity for AI systems, AI in combination products and SaMD, vendor management, and future trends
Target Audience:
- Validation Engineers and CSV Specialists
- Quality Assurance Professionals
- Data Scientists and AI/ML Engineers
- Regulatory Affairs Professionals
- IT and Cybersecurity Professionals
- Senior Management and AI Program Leaders
- Auditors and Inspectors
Pricing: $399.00 with group discounts available.
FAQ:
- Why does traditional CSV break when applied to AI? AI systems are adaptive and can learn over time, making static validation insufficient.
- What is the GAMP Guide: Artificial Intelligence? The ISPE GAMP Guide: Artificial Intelligence bridges established GAMP concepts with the unique characteristics of AI systems.
- What is Draft Annex 22? Draft Annex 22 is a new EU GMP Annex that provides a dedicated regulatory framework for AI models in the GMP environment.
- How do you validate AI systems? AI validation requires data governance, model drift monitoring, bias assessment, and explainability.
- What is the difference between AI validation and traditional software validation? AI validation requires ongoing monitoring and retraining governance due to the adaptive nature of AI systems.
Enroll Now: https://www.gxptrainings.com/courses/validating-ai-in-gxp-a-comprehensive-training/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
